Natural Science Laboratory, Division of Medicinal and Pharmaceutical Chemistry, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India.
J Med Chem. 2022 Aug 25;65(16):10709-10754. doi: 10.1021/acs.jmedchem.1c01855. Epub 2022 Aug 15.
Among various matrix metalloproteinases (MMPs), MMPs having medium-size S1' pockets are established as promising biomolecular targets for executing crucial roles in cancer, cardiovascular diseases, and neurodegenerative diseases. However, no such MMP inhibitors (MMPIs) are available to date as drug candidates despite a lot of continuous research work for more than three decades. Due to a high degree of structural resemblance among these MMPs, designing selective MMPIs is quite challenging. However, the variability and uniqueness of the S1' pockets of these MMPs make them promising targets for designing selective MMPIs. In this perspective, the overall structural aspects of medium-size S1' pocket MMPs including the unique binding patterns of enzyme-inhibitor interactions have been discussed in detail to acquire knowledge regarding selective inhibitor designing. This overall knowledge will surely be a curtain raiser for the designing of selective MMPIs as drug candidates in the future.
在各种基质金属蛋白酶 (MMPs) 中,具有中等大小 S1'口袋的 MMPs 被确立为有前途的生物分子靶标,在癌症、心血管疾病和神经退行性疾病中发挥关键作用。然而,尽管三十多年来进行了大量的连续研究工作,但目前尚无此类 MMP 抑制剂 (MMPI) 可用作候选药物。由于这些 MMPs 之间具有高度的结构相似性,因此设计选择性 MMPIs 具有相当大的挑战性。然而,这些 MMP 的 S1'口袋的可变性和独特性使它们成为设计选择性 MMPIs 的有前途的靶标。在这方面,详细讨论了中等大小 S1'口袋 MMPs 的整体结构方面,包括酶-抑制剂相互作用的独特结合模式,以获得有关选择性抑制剂设计的知识。这些整体知识肯定会为未来作为候选药物设计选择性 MMPIs 拉开序幕。